US Broker Ratings

IDEXX Laboratories (IDXX) Investor Outlook: Unpacking a 27.67% Upside Potential

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing the attention of investors with its impressive market presence and growth..

Repligen Corporation (RGEN): Analyst Consensus Highlights Strong Buy Ratings and 53% Potential Upside

For investors with a keen eye on the healthcare sector, Repligen Corporation (NASDAQ: RGEN) presents a compelling case. With a market capitalization of $6.61 billion, this U.S.-based life sciences company..

Danaher Corporation (DHR) Stock Analysis: Promising 42.81% Upside According to Analysts

Danaher Corporation (NYSE: DHR), a prominent player in the healthcare sector, stands poised for a potential upswing. With a market capitalization of $123.97 billion, Danaher operates in the diagnostics and..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating a 51.79% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) presents an intriguing opportunity for investors with a knack for biotechnology stocks. With a market capitalization of $39.51 billion, this U.S.-based biopharmaceutical company is at..

Genmab A/S (GMAB) Stock Analysis: Exploring a 41.59% Potential Upside in the Biotech Sector

Genmab A/S (NASDAQ: GMAB), a prominent biotechnology company headquartered in Copenhagen, Denmark, is generating significant interest among investors, particularly due to its robust potential upside of 41.59%. As a key..

ICON plc (ICLR)

⚠️ No article content returned.

..

Globus Medical, Inc. (GMED) Stock Report: A 20.52% Upside Potential in the Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED), a key player in the healthcare sector specializing in medical devices, is catching the attention of investors with its impressive growth trajectory and promising market..

Regeneron Pharmaceuticals, Inc. (REGN)

⚠️ No article content returned.

..

CVS Health Corporation (CVS) Stock Analysis: A Promising 17.65% Upside Amid Robust Sector Positioning

Investor interest in CVS Health Corporation (NYSE: CVS) is on the rise as the healthcare giant navigates the evolving landscape of healthcare services with strategic precision. With a market capitalization..

Abbott Laboratories (ABT) Stock Analysis: Navigating a Potential 32.62% Upside with Solid Dividends

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector with a focus on medical devices, presents a compelling opportunity for investors seeking stability paired with growth potential. With a..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 45% Potential Upside Awaits Investors

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing the attention of investors with its robust growth potential and compelling..

West Pharmaceutical Services (WST): An In-Depth Stock Analysis Reveals 16.35% Potential Upside

As healthcare continues to be a focal point of global investment, West Pharmaceutical Services, Inc. (NYSE: WST) stands out as a robust player in the Medical Instruments & Supplies industry...

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 31.61% Potential Upside in the Healthcare Tech Market

Tempus AI, Inc. (TEM) is carving out a distinctive niche within the healthcare technology sector by harnessing advanced AI capabilities to drive innovation in health information services. Based in Chicago..

Hologic, Inc. (HOLX) Stock Analysis: Exploring the Healthcare Giant’s Strong Position with Limited Upside

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, particularly in medical instruments and supplies, boasts a robust market capitalization of $16.97 billion. With its headquarters in Marlborough,..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A 28% Upside in Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 28.16%, according to the latest analyst ratings. As a..

Incyte Corporation (INCY) Stock Analysis: Unveiling a 12% Potential Upside in the Biotech Sector

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, presents an intriguing investment opportunity with its robust pipeline and a notable potential upside of nearly 12%. As the..

Chemed Corp (CHE) Stock Analysis: Navigating Healthcare Growth with a 5.77% Upside Potential

Chemed Corp (NYSE: CHE), a stalwart in the healthcare sector, has carved a notable niche within the medical care facilities industry. With a market capitalization of $5.6 billion, the company..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Examining the Strategic Healthcare Player with a 26.5% Revenue Growth

Medpace Holdings, Inc. (NASDAQ: MEDP) stands out as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $11.92 billion, this..

Royalty Pharma plc (RPRX): Analyst Consensus Signals Potential Upside Amid Biotech Growth

Royalty Pharma plc (NASDAQ: RPRX) stands as a prominent player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $29.33 billion, this New York-based company..

Medtronic plc (MDT) Stock Analysis: Uncovering a 35% Upside Potential

Medtronic plc (MDT), a giant in the medical devices industry, commands a market capitalization of $102.71 billion and stands as a vital player in the healthcare sector. Headquartered in Galway,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds